In High 2 or Basal groups, downregulation of GSTA1, GSTM1, GSTM2, and GSTT1 gene expression can be correlated with the impaired ability to eliminate carcinogenic compounds and increased cancer risk. The gene discussed is GSTA1; the disease is cancer.